| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 07/01/1999 | CA2316248A1 Methods and compositions for the delivery of pharmaceutical agents and/or the prevention of adhesions |
| 07/01/1999 | CA2316018A1 Novel pharmaceutical compositions of uridine triphosphate |
| 07/01/1999 | CA2315974A1 Insulin-like growth factor binding protein fragments and the utilization thereof |
| 07/01/1999 | CA2315941A1 Novel substituted pyridine compounds useful as modulators of acetylcholine receptors |
| 07/01/1999 | CA2315782A1 Pharmaceutical compositions comprising micelles comprising lipophilic glucocorticosteroid and only one surfactant |
| 07/01/1999 | CA2315720A1 Inhibition of p38 kinase activity using substituted heterocyclic ureas |
| 07/01/1999 | CA2315620A1 Triazine compounds for treatment of cns disorders |
| 07/01/1999 | CA2315539A1 Compositions derived from mycobacterium vaccae and methods for their use |
| 07/01/1999 | CA2315280A1 Method for quantifying denatured ldl |
| 07/01/1999 | CA2315226A1 Hypoglycemic imidazoline compounds |
| 07/01/1999 | CA2315201A1 Application of enzyme prodrugs as anti-infective agents |
| 07/01/1999 | CA2315082A1 Process for purifying a solution of an ampicillin pro-drug ester |
| 07/01/1999 | CA2315070A1 Ortho-anthranilamide derivatives as anti-coagulants |
| 07/01/1999 | CA2315066A1 Process for the preparation of paroxetine hydrochloride |
| 07/01/1999 | CA2315032A1 Dna pharmaceutical formulations comprising citrate or triethanolamine and combinations thereof |
| 07/01/1999 | CA2314989A1 A novel phosphate salt of isopropyl-methyl-[2-(3-n-propoxyphenoxy)ethyl]amine |
| 07/01/1999 | CA2314988A1 Process for the preparation of isopropyl-methyl-¬2-(3-n-propoxyphenoxy)ethyl|amine |
| 07/01/1999 | CA2314980A1 Compounds of heteroaryl substituted imidazole, their pharmaceutical compositions and uses |
| 07/01/1999 | CA2314925A1 Novel sulfonamide substituted chroman derivatives useful as beta-3 adrenoreceptor agonists |
| 07/01/1999 | CA2314868A1 Topical carbamazepine formulations and methods of use |
| 07/01/1999 | CA2314452A1 New use of local anaesthetics against vascular headaches |
| 07/01/1999 | CA2314401A1 Nitrogen containing heteroaromatics with ortho-substituted p1's as factor xa inhibitors |
| 07/01/1999 | CA2313386A1 Use of 3-benzoyl-phenylacetic acids, esters, or amides for treatment of glc1a glaucoma |
| 07/01/1999 | CA2313316A1 Compositions comprising cannabinoids |
| 07/01/1999 | CA2313232A1 Treatment of glc1a glaucoma with non-steroidal glucocorticoid antagonists |
| 07/01/1999 | CA2313163A1 Pharmaceutical compositions |
| 07/01/1999 | CA2312712A1 Novel acylguanidine derivatives as inhibitors of bone resorption and as vitronectin receptor antagonists |
| 07/01/1999 | CA2312070A1 1,4-diazacycloheptane derivatives |
| 07/01/1999 | CA2311294A1 Use of hyperbranched polymers and dendrimers comprising a particular group as film-forming agent, film-forming compositions comprising same and use particularly in cosmetics and pharmaceutics |
| 07/01/1999 | CA2309882A1 4-hydroxyquinoline-3-carboxamides and hydrazides as antiviral agents |
| 07/01/1999 | CA2307221A1 Polycyclic .alpha.-amino-e-caprolactams and related compounds |
| 07/01/1999 | CA2305436A1 Ace inhibitor-mmp inhibitor combinations |
| 07/01/1999 | CA2304959A1 Pharmaceutical composition for antagonizing ccr5 comprising anilide derivative |
| 07/01/1999 | CA2303483A1 Sag: sensitive to apoptosis gene |
| 07/01/1999 | CA2300205A1 Compositions for inhibiting gingivitis |
| 07/01/1999 | CA2300197A1 Thiourea and benzamide compounds, compositions and methods of treating or preventing inflammatory diseases and atherosclerosis |
| 07/01/1999 | CA2281710A1 Phytosterol composition for preventing alzheimer's disease |
| 06/30/1999 | EP0926237A2 Nucleic acid constructs for gene therapy, whose activity is influenced by inhibitors of cyclin-dependent kinases |
| 06/30/1999 | EP0926236A1 Binding partners for inhibitors of cyclin-dependent kinases and their use for inhibitor screening, diagnosis or therapy |
| 06/30/1999 | EP0926148A1 Benzo (C)quinolizine derivatives, their preparation and use as 5-alphareductases inhibitors |
| 06/30/1999 | EP0926145A1 Napthalene compounds, method for their preparation and pharmaceutical compositions containing them |
| 06/30/1999 | EP0926137A1 Picolin acid derivatives useful in the treatment of IL-1 and TNF mediated diseases |
| 06/30/1999 | EP0925789A1 Topical azithromycin compositions for the treatment of ocular infections |
| 06/30/1999 | EP0925788A1 Drugs for relieving diabetic vascular lesion |
| 06/30/1999 | EP0925787A1 Drugs for ameliorating pulmonary circulation |
| 06/30/1999 | EP0925786A1 Remedies for ischemic diseases |
| 06/30/1999 | EP0925781A1 Skin whitening composition |
| 06/30/1999 | EP0925779A1 Cosmetic composition containing cinnamic acid or at least a derivative and its use |
| 06/30/1999 | EP0925503A1 Materials and methods relating to the diagnosis and treatment of diabetes and obesity |
| 06/30/1999 | EP0925356A1 New antigen presenting cells, a process for preparing the same and their use as cellular vaccines |
| 06/30/1999 | EP0925310A1 Sulfated polysaccharides and uses thereof in medical treatment |
| 06/30/1999 | EP0925307A1 Enzyme and dna sequence encoding same |
| 06/30/1999 | EP0925303A1 Phosphinic acid amides as matrix metalloprotease inhibitors |
| 06/30/1999 | EP0925301A1 Highly lipophilic camptothecin derivatives |
| 06/30/1999 | EP0925299A1 Pyrazolopyridine compound and pharmaceutical use thereof |
| 06/30/1999 | EP0925298A1 Substituted 6,6-hetero-bicyclic derivatives |
| 06/30/1999 | EP0925297A1 Endothelin receptor antagonists |
| 06/30/1999 | EP0925294A1 Substituted 2(2,6-dioxopiperidin-3-yl)phthalimides and -1-oxoisoindolines and method of reducing tnf-alpha levels |
| 06/30/1999 | EP0925291A1 Spirocyclic dopamine receptor subtype ligands |
| 06/30/1999 | EP0925289A1 Matrix metalloproteinase inhibitors |
| 06/30/1999 | EP0925287A1 Heterocyclic metalloprotease inhibitors |
| 06/30/1999 | EP0925286A1 Substituted pyrimidine derivatives and their pharmaceutical use |
| 06/30/1999 | EP0925284A1 New polycyclic phthalazin derivatives and their use |
| 06/30/1999 | EP0925278A1 Cytostatic hydroxamic acid derivatives |
| 06/30/1999 | EP0925273A1 Pharmaceutical composition containing 4-oxo-butynic acids |
| 06/30/1999 | EP0925070A1 Antifungal combination therapy |
| 06/30/1999 | EP0925069A1 Means for treating prostate hypertrophy and prostate cancer |
| 06/30/1999 | EP0925068A1 Pharmaceutical composition containing polyphenols from grapes, in particular resveratrol, and yeast extracts |
| 06/30/1999 | EP0925065A1 Water miscible erythromycin solutions |
| 06/30/1999 | EP0925064A1 5-ANDROSTENE 3 beta,17alpha DIOL AS AN INHIBITOR OF TUMOR GROWTH |
| 06/30/1999 | EP0925062A1 Therapeutic utilities of verapamil enantiomers |
| 06/30/1999 | EP0925060A1 Fast decomposing pellets |
| 06/30/1999 | EP0925046A1 Topical formulations and methods for treating hemorrhoidal pain |
| 06/30/1999 | EP0924986A1 Antioxidant derived from lentil and its preparation and uses |
| 06/30/1999 | EP0924985A1 Method for inhibiting the expression of fas |
| 06/30/1999 | EP0924983A1 S(-)-tolterodine in the treatment of urinary and gastrointestinal disorders |
| 06/30/1999 | EP0782567B1 Isothiourea derivatives as no synthase inhibitors |
| 06/30/1999 | EP0756602B1 Cck or gastrin modulating 5-heterocyclic-1,5-benzodiazepines |
| 06/30/1999 | EP0749429B1 3,5-disubstituted and 3,5,6-trisubstituted 2-isoxazolines and isoxazoles, process for preparing the same and their use as medicaments |
| 06/30/1999 | EP0701606A4 Method of enhancing thrombolysis |
| 06/30/1999 | EP0699198B1 N-benzoylmethyl substituted paroxetine derivatives |
| 06/30/1999 | EP0663899B1 Substituted kynurenines, a process for their preparation, and use as medicaments |
| 06/30/1999 | EP0637956B1 Use of remacemide for the treatment of parkinson's disease |
| 06/30/1999 | EP0612521B1 Fomentation containing ketorolac |
| 06/30/1999 | EP0526540B1 Use of 5-ht4-receptor antagonists in the treatment of atrial fibrillation, including the prevention of stroke |
| 06/30/1999 | EP0466768B2 Short-chain triglycerides |
| 06/30/1999 | CN1221452A Hybrid interferon compositions and method of use |
| 06/30/1999 | CN1221449A Modulators of TNF receptor associated factor (TRAF), their preparation and use |
| 06/30/1999 | CN1221426A Fragments of leptin (OB protein) |
| 06/30/1999 | CN1221424A 肽衍生物 Peptide derivatives |
| 06/30/1999 | CN1221421A Novel water-soluble c-ring analogues of 20(S)-camptothecin |
| 06/30/1999 | CN1221420A Novel water-soluble analogues of 20(S)-camptothecin |
| 06/30/1999 | CN1221419A Amide derivatives |
| 06/30/1999 | CN1221418A Preparation of (7S, trans)-2-(2-pyrimidinyl)-7-(hydroxymethyl) octahydro-2h-pyrido [1,2-A] pyrazine |
| 06/30/1999 | CN1221417A Thiazolidinedione compounds having antidiabetic, hypolipidaemic, antihypertensive properties, process for their preparation and pharmaceutical compositions thereof |
| 06/30/1999 | CN1221416A Novel Heterocyclic compounds having antidiabetic, hypolipidaemic, antihypertensive properties, process for their preparation and pharmaceutical compositions containing them |
| 06/30/1999 | CN1221415A Novel antidiabetic compounds having hypolipidaemic, antihypertensive properties, process for their preparation and pharmaceutical compositions containing them |
| 06/30/1999 | CN1221414A Novel benzothiepines having activity as inhibitors of ileal bile acid transport and taurocholate uptake |
| 06/30/1999 | CN1221410A Novel substituted 2,4-thiazolidine diketone derivatives, method for preparation thereof and pharmaceutical compositions containing the same |
| 06/30/1999 | CN1221409A Bibenzo-oxazepine and dioxepine derivatives and their use as anti-tumor agents |